Details of the Drug

General Information of Drug (ID: DM0HSJK)

Drug Name
FF-10501-01
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 1/2 [1]
Chronic myelogenous leukaemia 2A20.0 Phase 1/2 [1]
Haematological malignancy 2B33.Y Phase 1/2 [2]
Myelodysplastic syndrome 2A37 Phase 1/2 [1]
Structure
3D MOL 2D MOL
Cross-matching ID
PubChem CID
124343
TTD ID
D02BVW
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cell differentiation (CD) TTF63Z1 NOUNIPROTAC Stimulator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02193958) Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies. U.S. National Institutes of Health.